173 Episodo

  1. Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's

    Publicado: 6/3/2024

  2. Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer

    Publicado: 9/2/2024

  3. Ep153: Rick Young on Studying Gene Expression for Drug Discovery

    Publicado: 22/1/2024

  4. Ep152: Jens Eckstein on Investing in Healthy Aging

    Publicado: 10/1/2024

  5. Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer

    Publicado: 26/12/2023

  6. Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance

    Publicado: 13/12/2023

  7. Ep149: Nancy Stagliano on Precision Neuroscience

    Publicado: 29/11/2023

  8. Ep148: Diana Brainard on the Fight Against Infectious Disease

    Publicado: 13/11/2023

  9. Ep147: Reid Huber on Investing in the Future of Medicine

    Publicado: 1/11/2023

  10. Ep146: Jeff Huber on Life in Tech and Biotech

    Publicado: 17/10/2023

  11. Ep145: Lori Lyons-Williams on Targeted Radiopharmaceuticals for Cancer

    Publicado: 3/10/2023

  12. Ep144: Turning the Tables, Rob Perez Interviews Me

    Publicado: 19/9/2023

  13. Ep143: Zach Weinberg and Alexis Borisy on Freeing the Biotech Founders

    Publicado: 6/9/2023

  14. Ep142: Fred Appelbaum on how 'Living Medicine' Came to Be

    Publicado: 24/8/2023

  15. Ep141: Colin Hill on Digging Deep into Data, Finding New Drug Targets

    Publicado: 8/8/2023

  16. Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas

    Publicado: 24/7/2023

  17. Ep139: Kevin Conroy on Early Detection of Cancer

    Publicado: 10/7/2023

  18. Ep138: Jodie Morrison on Becoming a Biotech CEO

    Publicado: 27/6/2023

  19. Ep137: Aaron Ring on Immunotherapy for Cancer & More

    Publicado: 14/6/2023

  20. Ep136: Deborah Palestrant on Building Biotech Startups

    Publicado: 30/5/2023

2 / 9

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Visit the podcast's native language site